Also known as: Rapaflo; Urief
Silodosin is a highly selective alpha-1A adrenoceptor antagonist indicated for the symptomatic treatment of benign prostatic hyperplasia. Its high selectivity for the alpha-1A receptor in the prostate minimizes cardiovascular side effects. Mediocon Inc manufactures GMP-certified Silodosin API at its Aurangabad facility.
| Parameter | Specification |
|---|---|
| CAS Number | 160970-54-7 |
| Molecular Formula | C₂₅H₃₂F₃N₃O₄S |
| Molecular Weight | 495.60 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Alpha-1A Adrenoceptor Antagonist |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Silodosin — CAS 160970-54-7 (CAS 160970-54-7) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Silodosin — CAS 160970-54-7 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance